BioWorld MedTech

June 3, 2010

Roche wins FDA approval for Elecsys anti-HCV test

Roche Diagnostics (Indianapolis) said the FDA has granted premarket approval for its Elecsys Antibody to hepatitis C virus (anti-HCV) assay. (Medical Device Daily) Read More

Volcano expanding platform for cardiologists to see-and-treat

Washington roundup: Dexcom: FDA flip-flopped on wire fracture device reports

Report from Europe: Concentric gets expanded CE mark for its DAC catheters

MDD's food for med-tech thought

Financings roundup: AmSurg closes on $375M revolving credit facility

Restructuring roundup: Court approves chapter 11 plan for GSI Group

Patent watch: RemitData wins new patent for Electronic Remittance Advice

Agreements/contracts: Encision in purchasing deal with HealthTrust

People in the News

SurModics' CEO Barclay to head Hansen Medical

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...